Fisher Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $445K | Buy |
2,339
+71
| +3% | +$12.2K | ﹤0.01% | 834 |
|
|
2026
Q1 | $383K | Sell |
2,268
-495
| -18% | -$84.6K | ﹤0.01% | 844 |
|
|
2025
Q4 | $466K | Buy |
2,763
+563
| +26% | +$91.4K | ﹤0.01% | 790 |
|
|
2025
Q3 | $318K | Sell |
2,200
-67
| -3% | -$9.14K | ﹤0.01% | 880 |
|
|
2025
Q2 | $287K | Sell |
2,267
-136
| -6% | -$16.7K | ﹤0.01% | 892 |
|
|
2025
Q1 | $307K | Sell |
2,403
-141
| -6% | -$19.1K | ﹤0.01% | 888 |
|
|
2024
Q4 | $336K | Buy |
2,544
+410
| +19% | +$57.6K | ﹤0.01% | 843 |
|
|
2024
Q3 | $311K | Sell |
2,134
-529
| -20% | -$76.5K | ﹤0.01% | 828 |
|
|
2024
Q2 | $366K | Sell |
2,663
-485
| -15% | -$64.7K | ﹤0.01% | 842 |
|
|
2024
Q1 | $432K | Buy |
+3,148
| New | +$430K | ﹤0.01% | 794 |
|
|
2023
Q4 | – | Sell |
-1,691
| Closed | -$207K | – | 1049 |
|
|
2023
Q3 | $207K | Sell |
1,691
-331
| -16% | -$42.1K | ﹤0.01% | 1014 |
|
|
2023
Q2 | $257K | Buy |
2,022
+199
| +11% | +$25.9K | ﹤0.01% | 979 |
|
|
2023
Q1 | $235K | Sell |
1,823
-5
| -0.3% | -$655 | ﹤0.01% | 956 |
|
|
2022
Q4 | $240K | Buy |
+1,828
| New | +$236K | ﹤0.01% | 949 |
|
|
2022
Q3 | – | Sell |
-2,007
| Closed | -$236K | – | 968 |
|
|
2022
Q2 | $236K | Sell |
2,007
-979
| -33% | -$116K | ﹤0.01% | 847 |
|
|
2022
Q1 | $389K | Buy |
2,986
+781
| +35% | +$102K | ﹤0.01% | 774 |
|
|
2021
Q4 | $337K | Buy |
2,205
+260
| +13% | +$40.3K | ﹤0.01% | 827 |
|
|
2021
Q3 | $314K | Sell |
1,945
-412
| -17% | -$69.3K | ﹤0.01% | 791 |
|
|
2021
Q2 | $386K | Buy |
2,357
+101
| +4% | +$15.6K | ﹤0.01% | 763 |
|
|
2021
Q1 | $340K | Sell |
2,256
-23
| -1% | -$3.65K | ﹤0.01% | 764 |
|
|
2020
Q4 | $345K | Buy |
2,279
+174
| +8% | +$24.9K | ﹤0.01% | 765 |
|
|
2020
Q3 | $285K | Buy |
2,105
+340
| +19% | +$46.1K | ﹤0.01% | 751 |
|
|
2020
Q2 | $241K | Sell |
1,765
-435
| -20% | -$55.5K | ﹤0.01% | 755 |
|
|
2020
Q1 | $237K | Sell |
2,200
-3,137
| -59% | -$361K | ﹤0.01% | 707 |
|
|
2019
Q4 | $643K | Buy |
5,337
+2,946
| +123% | +$329K | ﹤0.01% | 633 |
|
|
2019
Q3 | $238K | Sell |
2,391
-8,681
| -78% | -$909K | ﹤0.01% | 765 |
|
|
2019
Q2 | $1.21M | Buy |
+11,072
| New | +$1.18M | ﹤0.01% | 589 |
|
|
2019
Q1 | – | Sell |
-7,659
| Closed | -$739K | – | 824 |
|
|
2018
Q4 | $739K | Buy |
7,659
+5,772
| +306% | +$613K | ﹤0.01% | 616 |
|
|
2018
Q3 | $230K | Buy |
+1,887
| New | +$222K | ﹤0.01% | 751 |
|
|
2018
Q2 | – | Sell |
-2,708
| Closed | -$289K | – | 822 |
|
|
2018
Q1 | $289K | Sell |
2,708
-388
| -13% | -$43K | ﹤0.01% | 683 |
|
|
2017
Q4 | $331K | Sell |
3,096
-5,832
| -65% | -$623K | ﹤0.01% | 715 |
|
|
2017
Q3 | $993K | Buy |
8,928
+2,478
| +38% | +$265K | ﹤0.01% | 562 |
|
|
2017
Q2 | $667K | Buy |
+6,450
| New | +$635K | ﹤0.01% | 575 |
|
|
2017
Q1 | – | Sell |
-2,424
| Closed | -$214K | – | 744 |
|
|
2016
Q4 | $214K | Sell |
2,424
-1,827
| -43% | -$166K | ﹤0.01% | 679 |
|
|
2016
Q3 | $410K | Buy |
+4,251
| New | +$404K | ﹤0.01% | 593 |
|
Other funds holding IBB
CB
Fisher Asset Management's IBB Position: Q2 2026 in Review
Fisher Asset Management increased its iShares Biotechnology ETF (IBB) stake by 3.1% in Q2 2026, buying an estimated $12.2K and bringing the position to 2,339 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #834.
Fisher Asset Management first reported a position in IBB in Q3 2016 and has held it in 35 quarters since. The position peaked at $1.21M in Q2 2019. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Fisher Asset Management held 2,339 shares of iShares Biotechnology ETF worth $445K as of Q2 2026.
- Fisher Asset Management bought 71 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.2K.
- iShares Biotechnology ETF made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #834 holding.
- Fisher Asset Management first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 35 quarters since.
- Fisher Asset Management's iShares Biotechnology ETF position peaked at $1.21M in Q2 2019.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.